Combined capabilities provide scientists with access to new and existing immortalized cell lines for use in broad research applications and clinical markets.
Material deposit agreements established with over 30 institutions will accelerate biological material distribution to global research community.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.
